Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the 1 month safety and tolerability after multiple
oral doses of AZD1656 in patients with Type 2 Diabetes Mellitus Treated with Insulin